Martinez, M. W., Tucker, A. M., Bloom, O. J., Green, G, DiFiori, J. P., Solomon, G, Phelan, D, Kim, J. H., Meeuwisse, W, Sills, A. K., Rowe, D, Bogoch, I. I., Smith, P. T., Baggish, A. L., Putukian, M & Engel, D. J. (2021). Prevalence of inflammatory heart disease among professional athletes with prior COVID-19 infection who received systematic return-to-play cardiac screening. JAMA Cardiology, 4.3.2021 , 1-8. Zugriff am 09.03.2021 unter https://doi.org/10.1001/jamacardio.2021.0565
APA-Zitierstil (7. Ausg.)Martinez, M. W., Tucker, A. M., Bloom, O. J., Green, G., DiFiori, J. P., Solomon, G., . . . Engel, D. J. (2021). Prevalence of inflammatory heart disease among professional athletes with prior COVID-19 infection who received systematic return-to-play cardiac screening. JAMA Cardiology, 4.3.2021, 1-8.
Chicago-Zitierstil (17. Ausg.)Martinez, M. W., et al. "Prevalence of Inflammatory Heart Disease Among Professional Athletes with Prior COVID-19 Infection Who Received Systematic Return-to-play Cardiac Screening." JAMA Cardiology 4.3.2021 (2021): 1-8.
MLA-Zitierstil (9. Ausg.)Martinez, M. W., et al. "Prevalence of Inflammatory Heart Disease Among Professional Athletes with Prior COVID-19 Infection Who Received Systematic Return-to-play Cardiac Screening." JAMA Cardiology, 4.3.2021, 2021, pp. 1-8.